Pharmacological Evaluation of Halogenated and Non-halogenated Arylpiperazin-1-yl-ethyl-benzimidazoles as D2 and 5-HT2A Receptor Ligands
2011
Autori:
Tomić, Mirko![](/themes/MirageIBISS/images/orcid.png)
Ignjatović, Đurđica
![](/themes/MirageIBISS/images/orcid.png)
Tovilović-Kovačević, Gordana
![](/themes/MirageIBISS/images/orcid.png)
Andrić, Deana
Penjišević, Jelena
Kostić-Rajačić, Slađana
Tip dokumenta:
Članak u časopisu (Objavljena verzija)
![](/themes/MirageIBISS//images/creativecommons/arr.png)
© 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Metapodaci
Prikaz svih podataka o dokumentuApstrakt:
Five groups of previously synthesized and initially screened non-substituted and 4-halogenated arylpiperazin-1-yl-ethyl-benzimidazoles were estimated for their in-vitro binding affinities at the rat D2, 5-HT2A, and a1-adrenergic receptors. Among all these compounds, 2-methoxyphenyl and 2-chlorophenyl piperazines demonstrate the highest affinities for the tested receptors. The effects of 4-halogenation of benzimidazoles reveal that substitution with bromine may greatly increase the affinity of the compounds for the studied receptors, while the effect of substitution with chlorine is less remarkable. Most of the tested components show 5-HT2A/D2 pKi binding ratios slightly above or less than 1, while only 4-chloro-6-(2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-1H-benzimidazole expresses an appropriate higher binding ratio (1.14), which was indicated for atypical neuroleptics. This compound exhibits a non-cataleptic action in rats and prevents d-amphetamine-induced hyperlocomotion in mice, which suggest its atypical antipsychotic potency.
Ključne reči:
Arylpiperazines; Atypical antipsychotics; D2 receptors; 5-HT2A receptors; Pharmacological screeningIzvor:
Archiv der Pharmazie, 2011, 344, 5, 287-291Finansiranje / projekti:
- Biomedicinska ispitivanja i razvoj nekih novih psihotropnih supstanci (RS-MESTD-MPN2006-2010-143032)
- Sinteza i karakterizacija biološki aktivnih supstanci i kompjuterska simulacija bioloških sistema (RS-MESTD-MPN2006-2010-142009)
DOI: 10.1002/ardp.200900168
ISSN: 0365-6233
PubMed: 21509803